Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - mercaptopurine monohydrate, quantity: 50 mg - tablet - excipient ingredients: pregelatinised maize starch; stearic acid; maize starch; magnesium stearate; lactose - treatment of acute leukaemia. it is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukaemia and acute myelogenous leukaemia.,mercaptopurine-link is also used in the treatment of chronic granulocytic leukaemia.

Singapore - Tiếng Anh - HSA (Health Sciences Authority)

leo pharma asia pte ltd - betamethasone dipropionate 0.643mg eqv betamethasone - gel - 0.5 mg/g

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

macleods pharmaceuticals limited - risedronate sodium (unii: ofg5exg60l) (risedronic acid - unii:km2z91756z) - risedronate sodium 5 mg - risedronate sodium tablets, usp are indicated for the treatment and prevention of osteoporosis in postmenopausal women. in postmenopausal women with osteoporosis, risedronate sodium tablets, usp reduces the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures [see clinical studies (14.1, 14.2) ]. risedronate sodium tablets, usp are indicated for treatment to increase bone mass in men with osteoporosis. risedronate sodium tablets, usp are indicated for the treatment and prevention of glucocorticoid-induced osteoporosis in men and women who are either initiating or continuing systemic glucocorticoid treatment (daily dosage of greater than or equal to 7.5 mg of prednisone or equivalent) for chronic diseases. patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin d. risedronate sodium tablets, usp are indicated for treatment of paget's disease of bone in men and women. the optimal duration of use has not been determined. t

Panama - Tiếng Anh - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

leo pharma a/s (leo pharmaceutical products ltd. a/s) - calcipotriol (monohidrato) - calcipotriol (monohidrato)....50.0 mcg / betametasona (dipropionato)....0.5 mg

Panama - Tiếng Anh - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

leo pharma a/s (leo pharmaceutical products ltd. a/s) - Ácido fusÍdico - Ácido fusÍdico ....20.00 mg

Tanzania - Tiếng Anh - Tanzania Medicinces & Medical Devices Authority

macleods pharmaceuticals limited, india - artesunate , amodiaquine - tablets - 100 + 270 mg

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

macleods pharmaceuticals limited - levofloxacin (unii: 6gnt3y5lmf) (levofloxacin anhydrous - unii:rix4e89y14) - levofloxacin tablets are indicated in adult patients for the treatment of nosocomial pneumonia due to methicillin-susceptible staphylococcus aureus, pseudomonas aeruginosa, serratia marcescens, escherichia coli, klebsiella pneumoniae, haemophilus influenzae, or streptococcus pneumoniae. adjunctive therapy should be used as clinically indicated. where pseudomonas aeruginosa is a documented or presumptive pathogen, combination therapy with an anti-pseudomonal β-lactam is recommended [see clinical studies (14.1) ]. levofloxacin tablets are indicated in adult patients for the treatment of community-acquired pneumonia due to methicillin-susceptible staphylococcus aureus , streptococcus pneumoniae (including multi-drug-resistant streptococcus pneumoniae [mdrsp]), haemophilus influenzae, haemophilus parainfluenzae, klebsiella pneumoniae, moraxella catarrhalis, chlamydophila pneumoniae, legionella pneumophila , or mycoplasma pneumoniae [see dosage and administration ( 2.1 ) and clinical studies (14.2 )]. mdrsp i

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

macleods pharmaceuticals limited - lurasidone hydrochloride (unii: o0p4i5851i) (lurasidone - unii:22ic88528t) - lurasidone hydrochloride is indicated for: • treatment of adult and adolescent patients (13 to 17 years) with schizophrenia [see clinical studies (14.1)]. • monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode associated with bipolar i disorder (other indication) [see clinical studies (14.2)]. • adjunctive treatment with lithium or valproate in adult patients with major depressive episode associated with bipolar i disorder (other indication) [see clinical studies (14.2)]. • known hypersensitivity to lurasidone hcl or any components in the formulation. angioedema has been observed with lurasidone [see adverse reactions (6.1)]. • strong cyp3a4 inhibitors (e.g., ketoconazole, clarithromycin, ritonavir, voriconazole, mibefradil, etc.) [see drug interactions (7.1)]. • strong cyp3a4 inducers (e.g., rifampin, avasimibe, st. john’s wort, phenytoin, carbamazepine, etc.) [see drug interactions (7.1)]. pregnancy exposure registry there is a pregna

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

zoetis inc. - dexmedetomidine (unii: 67vb76hono) (dexmedetomidine - unii:67vb76hono) - dexmedetomidine 0.09 mg in 1 ml -  sileo is indicated for the treatment of noise aversion in dogs. do not use sileo in dogs with severe cardiovascular, respiratory, liver or kidney disease, or in conditions of shock, severe debilitation, or stress due to extreme heat, cold or fatigue. do not use in dogs with hypersensitivity to dexmedetomidine or to any of the excipients. keep this client information sheet in the carton with the sileo dosing syringe review prior to giving each dose to your dog sileo (dexmedetomidine oromucosal gel) client information sheet for owner/handler use and safety this sheet summarizes the basic information about sileo and does not replace the instructions from your veterinarian. talk to your veterinarian if you have questions regarding any part of this information or if you want to know more about sileo. the syringe must be used in order to correctly dose the drug to your dog. you may use either a full, unused syringe or a partially used syringe that contains enough gel for the desired dose. what is sileo? sileo is

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - bleomycin sulfate, quantity: 15 iu - injection, powder for - excipient ingredients: sodium hydroxide; sulfuric acid - managment of the following neoplasms either as a single agent or in combination with other chemotherapeutic agents: squamous cell carcinoma, lymphomas, testicular carcinoma.